New warnings for Bextra.
D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D004348:Drug Labeling; D007555:Isoxazoles / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*; D000096926:Benzenesulfonamides
D016861:Cyclooxygenase Inhibitors; D007555:Isoxazoles; D013449:Sulfonamides; C406224:valdecoxib; D000096926:Benzenesulfonamides